Hyperinsulinemia: Clinical Trials

27 trials for Hyperinsulinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 unknown, 2 active not recruiting, 2 not yet recruiting. 10 Not applicable, 8 Phase 1, 3 Phase 2, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 4, Unknown 4, Active not recruiting 2
Phase 18Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 23Completed 3
Early Phase 11Withdrawn 1
Phase 41Completed 1

Follow Hyperinsulinemia: new trials by email Literature Review of Hyperinsulinemia trials Research Report on Hyperinsulinemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia
Phase 1Not yet recruitingColumbia University362027-01-012026-02-06
Effect of Insulin Lowering on Lipogenesis
Placebo, Diazoxide Oral Suspension, 2 mg per kg per dose, Deuterated water (2H2O/D2O), 70% - Hyperinsulinemia, Insulin Resistance
Phase 1RecruitingColumbia University252026-07-012026-07-06
Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in Patients With Extreme Glucose Metabolism Phenotypes
Monogenic Diabetes, Hyperinsulinemia
Not yet recruitingPeking University People's Hospital1202026-05-252026-06-02
Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults
Galacto-Oligosaccharide, Glucose - Postprandial Hyperglycemia, Hyperinsulinemia
Not applicableActive not recruitingUniversity of Aberdeen502025-01-172026-06-18
Diazoxide Suppression Test P&F Study
Diazoxide, 3 mg/kg per dose - Insulin Resistance, Hyperinsulinemia
Phase 1TerminatedColumbia University12024-10-232026-08-07
Graded Insulin Suppression Test P&F
Insulin regular, 2.0-3.2 mU/m2/min (euinsulinemia), Insulin regular, 32 mU/m2/min (hyperinsulinemia), Octreotide Acetate, 6-45 ng/kg/min - Insulin Resistance, Hyperinsulinemia
Phase 1CompletedColumbia University202024-09-162026-10-16
The Movie Theater Study
Fasting Trial, Fed Trial - Hyperglycemia, Postprandial, Hyperinsulinemia
Not applicableUnknownBall State University102024-03-242024-06-06
Pancreatic Clamp in NAFLD
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Prediabetic State
Phase 1CompletedColumbia University182023-08-292026-01-12
Glycemic Effect of Diazoxide in NAFLD
Diazoxide oral suspension, 1 mg per kg per dose, Diazoxide oral suspension, 2 mg per kg per dose, Placebo - Hyperinsulinemia, Insulin Resistance
Phase 1CompletedColumbia University222023-08-012026-09-30
Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β
Anakinra, Placebo - Hyperinsulinemia, PreDiabetes
Phase 2CompletedUniversity Hospital, Basel, Switzerland202023-06-152025-01-29
Effect of Alpelisib in Healthy Volunteers
Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg), Placebo (microcrystalline cellulose), 2 capsules, FreeStyle Libre Pro - Insulin Resistance, Hyperinsulinemia
Phase 1CompletedColumbia University232023-05-092023-12-21
Time-restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome
Time restricted eating, Normal ad libitum diet - PCOS, Hyperinsulinemia
Not applicableUnknownRuairí Floyd202021-05-052022-09-19
Saliva Insulin Responses to a Standardized Meal Tolerance Test in Humans
Dietary intervention - Diet Modification, Insulin Resistance
Not applicableUnknownUniversity of British Columbia1502019-01-042021-09-28
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Adrenal Gland Neoplasm, Hypertension
RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11502017-12-142026-10-26
Developing a Physiological Understanding of High Duration Activity
Muscular Exercise - Sedentary Lifestyle, Hyperinsulinemia
Not applicableUnknownUniversity of Houston602016-08-012023-05-19
A Cold Physical Treatment to Manage Insulin Resistance
Selective Cold, Electroacupuncture - Insulin Resistance, Hyperglycemia
Not applicableCompletedFirst Affiliated Hospital Xi'an Jiaotong University332016-07-012020-04-30
Reprometabolic Syndrome Mediates Subfertility in Obesity
Insulin, Intralipid, Dextrose - Obesity, Infertility
Not applicableActive not recruitingUniversity of Colorado, Denver842016-06-012026-03-02
Maternal Lifestyle and Neonatal Hypoglycemia
Daily brisk walking plus a carbohydrate-restricted diet - Hyperinsulinemia, Miscarriages
Not applicableCompletedHospital dos Servidores do Estado do Rio de Janeiro4802011-03-012016-09-29
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
Metformin, Dietary Modification - Acanthosis Nigricans, Hyperinsulinemia
CompletedHenry Ford Health System92009-02-012012-09-06
EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance
metformin and rosiglitazone - Hyperinsulinemia, Insulin Resistance
Phase 2CompletedNew York Medical College462008-01-012014-03-28

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Hyperinsulinism (27)  ·  Insulin Resistance (16)  ·  Obesity (11)  ·  Diabetes Mellitus (5)  ·  Non-alcoholic Fatty Liver Disease (5)  ·  Prediabetic State (5)  ·  Diabetes Mellitus, Type 2 (3)  ·  Dyslipidemias (3)  ·  Hyperglycemia (3)  ·  Pediatric Obesity (3)  ·  Glucose Intolerance (2)  ·  Hypertension (2)  ·  Motor Activity (2)  ·  Overweight (2)  ·  Sedentary Behavior (2)

Broader conditions

Metabolic Diseases (27)  ·  Nutritional and Metabolic Diseases (27)  ·  Glucose Metabolism Disorders (26)  ·  Body Weight (13)  ·  Nutrition Disorders (13)  ·  Overnutrition (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)  ·  Endocrine System Diseases (12)  ·  Overweight (11)  ·  Diabetes Mellitus (6)  ·  Digestive System Diseases (5)  ·  Fatty Liver (5)  ·  Liver Diseases (5)  ·  Lipid Metabolism Disorders (4)

Interventions

Insulin (6)  ·  Glucose (5)  ·  Metformin (5)  ·  Diazoxide (3)  ·  Glucagon (3)  ·  Octreotide (3)  ·  Deuterium Oxide (2)  ·  Diet Therapy (2)  ·  Human Growth Hormone (2)  ·  Rosiglitazone (2)  ·  4'-galactooligosaccharide (1)  ·  Alpelisib (1)  ·  Anticoagulants (1)  ·  Electroacupuncture (1)  ·  Fatty Acids, Nonesterified (1)

Sponsors

Columbia University (7)  ·  Yale University (2)  ·  Ball State University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Henry Ford Health System (1)  ·  Hospital dos Servidores do Estado do Rio de Janeiro (1)  ·  Jack Yanovski, M.D. (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  New York Medical College (1)  ·  Peking University People's Hospital (1)  ·  Ruairí Floyd (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

United States (19)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Ireland (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Joshua R Cook, MD, PhD (6)  ·  Bryant Keirns (1)  ·  Harriette R Mogul, MD MPH (1)  ·  Iltefat Hamzavi, M.D. (1)  ·  Jack A Yanovski, MD, PhD (1)  ·  Joshua R. Cook, MD, PhD (1)  ·  Karen Scott, PhD (1)  ·  Katherine N Bachmann, MD (1)  ·  Kathleen Mulligan (1)  ·  Li Qiang, Ph.D. (1)  ·  Lucy-Ann Behan, MD (1)  ·  Marc Donath, Prof. (1)  ·  Marc T Hamilton, Ph.D. (1)  ·  Maria A Sayeg-Porto, MD, PhD (1)  ·  Nanette Santoro, MD (1)

Results publications

PMID 17595270, PMID 18761646, PMID 21228310, PMID 25259787, PMID 25483291, PMID 26789348, PMID 29718281, PMID 33838870, PMID 38271099, PMID 38710978, PMID 41532393

NIH funding

K12DK133995 (2), P30DK063608 (2), 2023 (1), K23DK140614 (1), UL1TR001082 (1)